Imidapril Hydrochloride

CAS : 89396-94-1

Ref. TR-I275040

Informations sur le produit

• Nom: Imidapril Hydrochloride
• Synonymes: (4S)-3-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1-methyl-2-oxo-4-imidazolidinecarboxylic Acid Hydrochloride, (-)-3-[N-[1(S)-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanyl]-1-methyl-2-oxoimidazolidine-4(S)-carboxylic acid hydrochloride, (S)-3-[(S)-2-((S)-1-Ethoxycarbonyl-3-Phenyl-Propylamino)-Propionyl]-1-Methyl-2-Oxo-Imidazolidine-4-Carboxylic Acid Hydrochloride, 4-Imidazolidinecarboxylic acid, 3-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1-methyl-2-oxo-, hydrochloride (1:1), (4S)-, 4-Imidazolidinecarboxylic acid, 3-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1-methyl-2-oxo-, monohydrochloride, (4S)-, 4-Imidazolidinecarboxylic acid, 3-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1-methyl-2-oxo-, monohydrochloride, [4S-[3[R*(R*)],4R*]]-, Imidapril HCl, Imidapril hydrochloride, Novaloc, Novarok, Sh-6366, Ta-6366, Tanapril, Tanatril

Description

Applications Angiotensin converting enzyme (ACE) inhibitor. Antihypertensive.
References Demolis, P., et al.: Fundam. Clin. Pharmacol., 8, 80 (1994), Vandenburg, M.J., et al.: Br. J. Clin. Pharmacol., 37, 265 (1994),

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 441.91
• Formule: C₂₀H₂₇N₃O₆·ClH
• Couleur/Forme: White Solid
• InChI: InChI=1S/C20H27N3O6.ClH/c1-4-29-19(27)15(11-10-14-8-6-5-7-9-14)21-13(2)17(24)23-16(18(25)26)12-22(3)20(23)28, /m0./s1, /h5-9,13,15-16,21H,4,10-12H2,1-3H3,(H,25,26), 1H/t13-,15-,16-
• Code InChI: InChIKey=LSLQGMMMRMDXHN-GEUPQXMHSA-N
• SMILES: CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O.Cl